Gastrointestinal Drug Classes: Proton Pump Inhibitors and Antiemetics
Updated
Proton pump inhibitors and antiemetics are among the most dispensed stomach drugs, and the exam asks about their suffixes, timing around meals and the interactions that come with long-term use. Each class below covers its drugs, what gets tested and practice questions.
Two skills carry most of the Medications domain, and each has its own quiz. The first is drug class identification: recognising which class a drug belongs to from its name or its stem, which is what the drug class identification quiz drills across every class. The second is brand and generic recall, because the exam switches between the two names freely and expects you to follow. Pair this guide with the brand and generic quiz until the brand and generic pairs in the tables below come back without effort.
Proton Pump Inhibitors
Also called PPIs, gastric H+/K+ ATPase inhibitors · suffix -prazole
Quick answer
- Mechanism: PPIs block the H+/K+ ATPase proton pump in the stomach's parietal cells, the final step of acid production, giving stronger and longer acid suppression than H2 blockers.
- Top uses and side effects: PPIs treat GERD and peptic ulcers, and are part of combination therapy for H. pylori infection; long-term use is linked to low magnesium, low vitamin B12, C. difficile infection, and a possible rise in fracture risk.
- Key interaction and counseling: omeprazole and esomeprazole can reduce the activation of clopidogrel (Plavix) through CYP2C19, and PPIs are taken before a meal (labeling for omeprazole and esomeprazole says at least 1 hour before eating).
What gets tested
- Recognizing the -prazole suffix and matching brand to generic (Prilosec is omeprazole, Nexium is esomeprazole, Protonix is pantoprazole)
- The mechanism: blocking the H+/K+ ATPase proton pump in gastric parietal cells
- The main uses: GERD, peptic ulcer disease, and part of H. pylori triple therapy
- Counseling that PPIs are taken before a meal, usually before breakfast (labeling for omeprazole and esomeprazole says at least 1 hour before eating)
- Long-term risks (low magnesium, low B12, C. difficile, possible fractures) and the clopidogrel interaction with omeprazole and esomeprazole
- Telling PPIs apart from H2 blockers such as famotidine (Pepcid)
What is not tested
You do not need to memorize CYP2C19 pharmacogenetics, the exact percentage of acid reduction, or prescribing decisions such as when to escalate a dose. Do not skip strengths and dosage forms, though: PTCE knowledge area 1.4 covers strengths and doses, dosage forms, routes of administration, special handling and administration instructions, and duration of therapy, so common strengths, the delayed-release dosage forms, and the 14-day over-the-counter course are all fair game. The emphasis is still on class recognition, brand-to-generic matching, the proton pump mechanism, the common uses, and the practical counseling and interaction points.
Why proton pump inhibitors matter
Omeprazole ranked #10 among the most dispensed medications in the United States in 2023, and has been in the top 10 every year since 2014. PPIs as a class appear throughout the Medications domain. Several are also sold over the counter, so technicians field questions about them constantly.
Proton Pump Inhibitors at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| omeprazole | Prilosec, Prilosec OTC | GERD, heartburn, peptic ulcers, H. pylori |
| esomeprazole | Nexium | GERD, erosive esophagitis, H. pylori |
| pantoprazole | Protonix | GERD, erosive esophagitis |
| lansoprazole | Prevacid | GERD, ulcers, heartburn |
| rabeprazole | Aciphex | GERD, duodenal ulcers, H. pylori |
| dexlansoprazole | Dexilant | GERD, erosive esophagitis |
Mechanism of action
Proton pump inhibitors block the H+/K+ ATPase enzyme, the proton pump, on the gastric parietal cells. This pump carries out the final step of acid secretion into the stomach, so blocking it shuts acid production off at the source. PPIs are prodrugs: they are absorbed in the small intestine, travel in the blood to the parietal cells, and are then activated by the acidic environment inside the cell's secretory canaliculi. Once activated they bind covalently to cysteine residues on the pump, so the block persists long after the drug has left the blood: acid inhibition lasts well beyond 24 hours, and full secretory activity returns only over about 3 to 5 days as the binding is slowly reversed and the cell builds new pumps. Many study guides call this binding irreversible; strictly, it is covalent and only slowly reversed, and pantoprazole's binding is the most resistant to reversal. This makes PPIs the most potent and longest acting acid reducers, stronger and longer lasting than H2 blockers such as famotidine, which block only one of the signals (histamine) that switch the pump on. As of 2015 the FDA-approved PPIs are omeprazole, esomeprazole, lansoprazole, dexlansoprazole, pantoprazole, and rabeprazole. Most are metabolized in the liver, largely by CYP2C19.
Common and important side effects
- Headache, diarrhea, nausea, abdominal pain, constipation, and gas are the most common
- Low magnesium (hypomagnesemia), which can cause muscle spasms, tremor, or heart rhythm changes with long-term use
- Possible low vitamin B12 and iron with prolonged use, along with slightly reduced calcium absorption (these are uncommon and often subclinical)
- An association with Clostridioides difficile (C. difficile) and other enteric infections, and possibly community-acquired pneumonia
- A possible increase in wrist, hip, and spine fractures with high doses or long-term use
- Rebound acid hypersecretion when stopping after prolonged use, and benign fundic gland polyps on the stomach lining
Key interactions
- Omeprazole and esomeprazole can reduce the activation of clopidogrel (Plavix) by inhibiting CYP2C19, which may weaken its antiplatelet effect
- By raising stomach pH, PPIs reduce absorption of drugs that need an acidic environment, such as ketoconazole, itraconazole, atazanavir, and some iron salts
- PPIs can slow the clearance of drugs such as phenytoin, warfarin, and diazepam, and can increase digoxin absorption
- St. John's wort can lower PPI levels and reduce their effect
Patient counseling notes
- Take the PPI before a meal, usually before breakfast, because the pumps are most active when food is eaten. Labeling for omeprazole and esomeprazole says at least 1 hour before eating; other references say 30 to 60 minutes before a meal
- Labels for pantoprazole (Protonix), rabeprazole (Aciphex), and dexlansoprazole (Dexilant) allow dosing with or without food, but pre-meal dosing is still the general counseling point for the class
- Swallow delayed-release tablets whole; do not split, crush, or chew them. Delayed-release capsules should be swallowed whole, but may be opened and the granules sprinkled on applesauce if the patient cannot swallow them; the granules themselves must not be chewed or crushed
- Full symptom relief can take 1 to 4 days, so a PPI is not meant for immediate heartburn relief
- Over-the-counter PPIs are for a 14-day course, taken no more than once every 4 months, unless a prescriber directs otherwise
- Report severe or watery diarrhea, muscle spasms, or unusual tiredness, which can signal C. difficile infection or low magnesium
Proton Pump Inhibitors practice questions
1. A prescription is written for Protonix. Which generic drug should the technician expect to dispense?
- A. Omeprazole
- B. Pantoprazole ✓
- C. Esomeprazole
- D. Famotidine
Answer: B. Protonix is the brand name for pantoprazole. Omeprazole (Prilosec) and esomeprazole (Nexium) are other PPIs that share the -prazole suffix, while famotidine is an H2 blocker.
2. Proton pump inhibitors suppress stomach acid by blocking which target?
- A. Histamine H2 receptors
- B. The H+/K+ ATPase proton pump in parietal cells ✓
- C. Muscarinic receptors
- D. Angiotensin-converting enzyme
Answer: B. PPIs block the H+/K+ ATPase, the proton pump on gastric parietal cells that carries out the final step of acid secretion. Blocking the pump itself gives stronger, longer acid suppression than blocking the histamine H2 receptor.
3. Which of the following is a proton pump inhibitor rather than an H2 blocker?
- A. Famotidine
- B. Omeprazole ✓
- C. Cimetidine
- D. Ranitidine
Answer: B. Omeprazole ends in -prazole and is a PPI. Famotidine, cimetidine, and ranitidine are H2 blockers that reduce acid by blocking histamine at the H2 receptor, a weaker and shorter acting approach. Note that ranitidine (Zantac) was withdrawn from the US market in 2020, so famotidine is the H2 blocker you will actually see dispensed.
4. How should a patient be counseled to take a once-daily proton pump inhibitor for best effect?
- A. At bedtime with a snack
- B. About 30 to 60 minutes before a meal ✓
- C. Only when heartburn occurs
- D. Together with an antacid at the same time
Answer: B. PPIs work best taken before a meal (usually before breakfast) because the proton pumps are most active when food stimulates acid production, so the drug is present and ready to block them. Labeling for omeprazole and esomeprazole specifies at least 1 hour before eating.
5. A patient takes clopidogrel (Plavix). Which proton pump inhibitor is most likely to reduce clopidogrel's activation and should prompt caution?
- A. Pantoprazole
- B. Omeprazole ✓
- C. Rabeprazole
- D. Dexlansoprazole
Answer: B. Omeprazole (and esomeprazole) inhibit CYP2C19, the enzyme that activates clopidogrel, so they can blunt its antiplatelet effect. The Plavix label tells patients to avoid omeprazole and esomeprazole. Pantoprazole has less effect on CYP2C19 and is often preferred when a PPI is needed with clopidogrel.
Proton Pump Inhibitors cheat sheet
- Suffix: -prazole
- Class: proton pump inhibitors (PPIs)
- Action: binds covalently to the H+/K+ ATPase proton pump in parietal cells and blocks it
- Uses: GERD, peptic ulcers, H. pylori triple therapy, Zollinger-Ellison syndrome
- Timing: take before a meal, usually before breakfast (at least 1 hour before eating for omeprazole and esomeprazole; pantoprazole, rabeprazole, and dexlansoprazole may be taken with or without food)
- Watch: low magnesium, low B12, C. difficile, possible fractures; stronger and longer acting than H2 blockers
- Interaction: omeprazole and esomeprazole reduce clopidogrel activation (CYP2C19)
Proton Pump Inhibitors: frequently asked questions
What is the difference between a PPI and an H2 blocker?
Both lower stomach acid, but a PPI such as omeprazole blocks the H+/K+ ATPase proton pump itself, the final step of acid production, while an H2 blocker such as famotidine only blocks the histamine signal that switches the pump on. PPIs give stronger and longer lasting acid suppression, while H2 blockers tend to work faster but more briefly.
Why are PPIs taken before meals?
The proton pumps are most active when a meal stimulates acid production, so taking the PPI before eating lets the drug be present and ready to block the pumps when they are working hardest. Labeling for omeprazole and esomeprazole says at least 1 hour before eating; other references say 30 to 60 minutes before a meal. Taking it after a meal, or at a time of day when no meal follows, makes it less effective.
What class of drug is omeprazole (Prilosec)?
Omeprazole is a proton pump inhibitor (PPI). The -prazole suffix identifies the class. PPIs block the H+/K+ ATPase proton pump in the stomach, giving longer-lasting acid suppression than H2 blockers such as famotidine.
What class of drug is pantoprazole (Protonix)?
Pantoprazole is a proton pump inhibitor (PPI). Of the PPIs it has the least effect on CYP2C19, which is why it is often preferred for patients taking clopidogrel.
Related drug classes
Antiemetics
Also called anti-nausea and anti-vomiting drugs · suffix -setron and others
Quick answer
- How they work: vomiting is triggered through several different receptors, so antiemetics are grouped by which one they block. Serotonin 5-HT3, dopamine D2, histamine H1, muscarinic, and substance P (NK1) are the five to know.
- Match the drug to the trigger: 5-HT3 blockers such as ondansetron for chemotherapy and post-operative nausea, antihistamines and scopolamine for motion sickness, and dopamine blockers such as metoclopramide and prochlorperazine for general nausea.
- Two boxed warnings worth knowing: promethazine can cause severe tissue injury on injection and is contraindicated under 2 years of age, and metoclopramide can cause tardive dyskinesia, which limits treatment duration.
What gets tested
- Matching brand to generic: Zofran is ondansetron, Phenergan is promethazine, Reglan is metoclopramide, Compazine is prochlorperazine, Antivert is meclizine
- The receptor each drug blocks and which situation it suits
- The orally disintegrating tablet form of ondansetron and why it exists
- Promethazine's boxed warnings: tissue injury with injection and the under-2 contraindication
- Metoclopramide's tardive dyskinesia boxed warning and the duration limit that follows
- QT prolongation with ondansetron
What is not tested
You are not expected to build an antiemetic regimen for chemotherapy or to choose between agents for a patient. Focus on the brand and generic pairs, the receptor grouping, the dosage forms, and the boxed warnings and counseling points. Strengths, dosage forms, routes, special handling, and duration of therapy fall under PTCE knowledge area 1.4, which makes the orally disintegrating tablets, suppositories, and transdermal patches in this class very fair targets.
Why antiemetics matter
Ondansetron is widely dispensed and appears in almost every setting a technician might work in, from retail to oncology to the hospital floor. The class is also unusually rich in dosage forms: orally disintegrating tablets for a patient who cannot keep anything down, suppositories, transdermal patches, and injections, which makes it a natural vehicle for dosage form and route questions.
Antiemetics at a glance
| Generic | Brand | Primary indication |
|---|---|---|
| ondansetron | Zofran, Zofran ODT | 5-HT3 blocker: chemotherapy, post-operative, and general nausea |
| granisetron | Sancuso (patch) | 5-HT3 blocker: chemotherapy-induced nausea |
| promethazine | Phenergan | H1 and D2 blocker: nausea, motion sickness, allergy |
| prochlorperazine | Compazine | D2 blocker: nausea and vomiting |
| metoclopramide | Reglan | D2 blocker and prokinetic: nausea, gastroparesis |
| meclizine | Antivert, Bonine | H1 blocker: motion sickness and vertigo |
| dimenhydrinate | Dramamine | H1 blocker: motion sickness |
| scopolamine | Transderm Scop | muscarinic blocker: motion sickness patch behind the ear |
| aprepitant | Emend | NK1 blocker: delayed chemotherapy-induced nausea |
Mechanism of action
Vomiting is coordinated by the brainstem, which gathers signals from several sources and acts on them through distinct receptor systems. That is why there is no single antiemetic: the useful drug depends on where the signal is coming from. The chemoreceptor trigger zone sits outside the blood-brain barrier and samples the blood for toxins, and it is dense in serotonin 5-HT3 and dopamine D2 receptors. Chemotherapy damages cells in the gut lining, which release large amounts of serotonin onto 5-HT3 receptors on the vagus nerve, which is why the -setron drugs work so well there and why they do comparatively little for motion sickness. Motion sickness originates in the vestibular system of the inner ear, which signals through histamine H1 and muscarinic acetylcholine receptors, so antihistamines such as meclizine and dimenhydrinate, and the anticholinergic scopolamine, are the agents that help. Dopamine blockers such as prochlorperazine and metoclopramide act at the chemoreceptor trigger zone, and metoclopramide adds a second useful action: it speeds gastric emptying, which is why it is used in gastroparesis. That same dopamine blockade is the reason metoclopramide and prochlorperazine can cause the movement side effects associated with antipsychotics, including tardive dyskinesia with prolonged metoclopramide use. Substance P acting on neurokinin-1 receptors drives the delayed phase of chemotherapy nausea, days after treatment, which is the niche aprepitant fills.
Common and important side effects
- Headache and constipation with the 5-HT3 blockers such as ondansetron
- QT interval prolongation with ondansetron, which is dose related
- Marked sedation with promethazine, dimenhydrinate, and meclizine
- Severe tissue injury including gangrene with injected promethazine, which carries a boxed warning
- Extrapyramidal symptoms with the dopamine blockers, and tardive dyskinesia with prolonged metoclopramide use, which carries a boxed warning
- Anticholinergic effects with scopolamine: dry mouth, blurred vision, urinary retention, and confusion in older adults
- Restlessness or akathisia with metoclopramide and prochlorperazine
- Low blood pressure and dizziness
Key interactions
- Other QT-prolonging drugs increase arrhythmia risk when combined with ondansetron
- Alcohol and other sedatives deepen the drowsiness of promethazine, meclizine, and dimenhydrinate
- Metoclopramide combined with an antipsychotic increases the risk of extrapyramidal symptoms, because both block dopamine
- Anticholinergic drugs add to the dry mouth, constipation, and confusion caused by scopolamine
- Metoclopramide speeds gastric emptying and can change the absorption of other oral drugs
- Serotonergic drugs combined with ondansetron carry a theoretical risk of serotonin syndrome
Patient counseling notes
- The orally disintegrating tablet dissolves on the tongue and does not need water, which is the point: it can be taken when the patient cannot keep liquids down. Handle it with dry hands and do not push it through the foil
- Apply the scopolamine patch behind the ear several hours before travel, and wash the hands after handling it, because rubbing the eye afterwards can blur vision
- Take motion sickness antihistamines before travel rather than after symptoms start
- Expect drowsiness with promethazine, meclizine, and dimenhydrinate, and avoid driving until the effect is known
- Report any involuntary movements of the face or tongue while taking metoclopramide, and do not continue it beyond the prescribed duration
- Report palpitations or fainting on ondansetron
- Sip clear fluids and take the dose before eating where directed, to get ahead of the nausea rather than chase it
Antiemetics practice questions
1. A prescription for Zofran ODT is received. Which generic drug and dosage form is being dispensed?
- A. Promethazine suppository
- B. Ondansetron orally disintegrating tablet ✓
- C. Metoclopramide oral solution
- D. Meclizine chewable tablet
Answer: B. Zofran is ondansetron, and ODT stands for orally disintegrating tablet. The form matters clinically: a patient who is actively vomiting cannot reliably swallow a tablet with water, but an ODT dissolves on the tongue.
2. Ondansetron relieves nausea by blocking which receptor?
- A. Histamine H1
- B. Serotonin 5-HT3 ✓
- C. Dopamine D2
- D. Muscarinic acetylcholine
Answer: B. Ondansetron and the other -setron drugs block serotonin 5-HT3 receptors, which is the pathway chemotherapy and surgery activate. Motion sickness runs through histamine and muscarinic receptors instead, which is why ondansetron is a poor choice for it.
3. Which antiemetic is best suited to preventing motion sickness?
- A. Ondansetron
- B. Meclizine ✓
- C. Aprepitant
- D. Granisetron
Answer: B. Motion sickness arises from the vestibular system of the inner ear, which signals through histamine H1 and muscarinic receptors. Meclizine, an antihistamine, targets that pathway. The 5-HT3 blockers work on the serotonin pathway and are much less useful for motion.
4. Which boxed warning applies to metoclopramide (Reglan)?
- A. Tendon rupture
- B. Tardive dyskinesia with prolonged use ✓
- C. Permanent tooth staining
- D. Severe neutropenia
Answer: B. Metoclopramide blocks dopamine, and prolonged blockade can produce tardive dyskinesia, an involuntary movement disorder that may be permanent. The boxed warning is why treatment duration is limited, typically to 12 weeks, and why any new facial or tongue movement is reported at once.
5. Promethazine injection carries a boxed warning for which risk?
- A. Severe tissue injury including gangrene ✓
- B. Permanent hearing loss
- C. Kidney stones
- D. Tooth discoloration
Answer: A. Injected promethazine can cause severe tissue damage, including gangrene, if it escapes the vein or is given into an artery. It is also contraindicated in children under 2 years of age because of the risk of fatal respiratory depression. Both warnings are frequently tested.
Antiemetics cheat sheet
- Group by receptor: 5-HT3, dopamine D2, histamine H1, muscarinic, and NK1
- Know these pairs: Zofran is ondansetron, Phenergan is promethazine, Reglan is metoclopramide, Compazine is prochlorperazine, Antivert is meclizine
- Chemotherapy and post-op nausea: ondansetron (5-HT3)
- Motion sickness: meclizine, dimenhydrinate (H1), scopolamine patch (muscarinic)
- Delayed chemotherapy nausea: aprepitant (NK1)
- Metoclopramide: boxed warning for tardive dyskinesia, limits duration; also a prokinetic for gastroparesis
- Promethazine: boxed warnings for tissue injury on injection and contraindicated under 2 years
- Ondansetron: watch QT prolongation. ODT form for patients who cannot swallow
Antiemetics: frequently asked questions
Why is ondansetron available as an orally disintegrating tablet?
A patient who is actively vomiting often cannot keep down a tablet taken with a glass of water. The orally disintegrating tablet dissolves on the tongue within seconds and is absorbed without any liquid, so the dose stays in. It should be handled with dry hands and peeled from the foil rather than pushed through it.
Why does ondansetron not help much with motion sickness?
Ondansetron blocks serotonin 5-HT3 receptors, the pathway activated by chemotherapy and surgery. Motion sickness starts in the vestibular system of the inner ear, which signals through histamine and muscarinic receptors instead. That is why an antihistamine such as meclizine or the scopolamine patch is used for travel sickness.
What class of drug is promethazine (Phenergan)?
Promethazine is a phenothiazine that blocks histamine H1 and dopamine D2 receptors, so it is used as an antiemetic, an antihistamine, and a sedative. It carries boxed warnings for severe tissue injury when injected and is contraindicated in children under 2 years of age.
Why is metoclopramide limited to a short course?
Metoclopramide blocks dopamine receptors, and sustained blockade can cause tardive dyskinesia, involuntary repetitive movements that may not reverse when the drug is stopped. The risk rises with duration of treatment, which is why the boxed warning drives a limit of about 12 weeks of therapy in most cases.
Related drug classes
More drug class guides
- Cardiovascular Drug Classes
- Antibiotic Drug Classes
- Mental Health and Neurology Drug Classes
- Pain Medication Classes
- Endocrine, Bone and Other Drug Classes
- All drug classes compared
Official sources
- StatPearls: Proton Pump Inhibitors (PPI) (NBK557385)
- MedlinePlus: Omeprazole
- MedlinePlus: Clopidogrel (PPI interaction)
- FDA label: Plavix (clopidogrel), avoid omeprazole or esomeprazole
- FDA label: Prilosec (omeprazole), take at least 1 hour before a meal
- ClinCalc DrugStats: Omeprazole (top-dispensed data)
- MedlinePlus: Ondansetron
- MedlinePlus: Promethazine
- MedlinePlus: Metoclopramide
- MedlinePlus: Prochlorperazine
- MedlinePlus: Meclizine
- MedlinePlus: Scopolamine Transdermal Patch
- ClinCalc DrugStats: Ondansetron (dispensing data)
PTCB Quiz Prep is an independent study resource, not affiliated with the Pharmacy Technician Certification Board. This guide is for exam preparation, not medical advice. Part of the PTCB Medications domain.
